Gene Name | Mir142 host gene (non-protein coding) | Gene Symbol | Mir142hg | |||
Chromosome | 11 | Genomic Location | chr11:87,569,000-87,570,900 | |||
Synonyms | A430104N18Rik, AW909330 | |||||
Links |
UCSC Genome Browser(chr11:87,569,000-87,570,900) NCBI Gene(78591) IGTC(Mir142hg,) UNIGene(Mm.) |
MGI(1925841) KEGG GENES(mmu:) EST Profile(mm.) |
Other Clone Trapped This Gene |
---|
Trap Vector | pU-21W | Cell Line | KAB6 (Albino B6) | Method | 5'-RACE |
Accession | AB462904 | GSS Location | chr11:87,569,078-87,569,115 | Size | 39 |
Sequence | GCACTTTGGATCCAGCTCTTCTCAGCTCTGCAGCATCAG | ||||
Links |
UCSC Browser(chr11:87,569,078-87,569,115) IGTC(Ayu21-KBW111) |
[AK020764] Mus musculus 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430104N18 product:unclassifiable, full insert sequence. |
Card ID | 1271 | ||||
Strain Name | B6-A430104N18RikGt(pU-21KBW)111Card | ||||
Internal Code | Ayu21-KBW111 | ||||
Description | This clone was isolated by using the exchangeable gene trap vector;pU-21W, and ES cell line; KAB6 (Albino B6). Mouse line has been established from this clone, and deposited to the CARD R-BASE. [Paper] "MiR-142 is required for Staphylococcus aureus clearance at skin wound sites via small GTPase-mediated regulation of the neutrophil actin cytoskeleton." Tanaka, K., Kim, S. E., Yano, H., Matsumoto, G., Ohuchida, R., Ishikura, Y., Araki, M., Araki, K., Park, S., Komatsu, T., Hayashi, H., Ikematsu, K., Tanaka, K., Hirano, A., Martin, P., Shimokawa, I., Mori, R., J. Invest, Dermatol., 137(4), 931-940 (2017). pii: S0022-202X(16)32664-1. doi: 10.1016/j.jid.2016.11.018. Epub 2016 Nov 25. PubMed ID:27894934. [Paper] "Identification and functional analysis of inflammation-related miRNAs in skin wound repair." Mori, R., Tanaka, K., Shimokawa, I., Dev. Growth Differ., 60, 306 (2018). doi: 10.1111/dgd.12542. Epub 2018 Jun 5. PubMed ID:29873073. [Paper] "Mir142 loss unlocks IDH2(R140)-dependent leukemogenesis through antagonistic regulation of HOX genes." Marshall, A., Kasturiarachchi, J., Datta, P., Guo, Y., Deltcheva, E., James, C., Brown, J., May, G., Anandagoda, N., Jackson, I., Howard, J. K., Ghazaly, E., Brooks, S., Khwaja, A., Araki, M., Araki, K., Linch, D., Lord, G. M., Enver, T., Nimmo, R., Sci Rep,10,19390(2020). doi: 10.1038/s41598-020-76218-8. Epub 2018 Jun 5. PubMed ID:33173219. [Paper] "MicroRNA-142 Critically Regulates Group 2 Innate Lymphoid Cell Homeostasis and Function." Roberts, L.B., Jowett, G.M., Read, E., Zabinski, T., Berkachy, R., Selkirk, M.E., Jackson, I., Niazi, U., Anandagoda, N., Araki, M., Araki, K., Kasturiarachchi, J., James, C., Enver, T., Nimmo, R., Reis, R., Howard, J.K., Neves J.F. and Lord, G.M., J. Immunol., 206, 2725-2739 (2021). doi: 10.4049,jimmunol.org.2000647,. PubMed ID:34021046. [Paper] "A gain-of-function mutation in microRNA 142 is sufficient to cause the development of T-cell leukemia in mice." Kawano, S., Araki, K., Bai, J., Furukawa, I., Tateishi, K., Yoshinobu, K., Usuki, S., Nimmo, R., Kaname, T., Toshihara, M., Takahashi, S., Sashida, G., Araki, M., Cancer Science, 114(7), 2821-2834(2023). doi: 10.1111/cas.15784. PubMed ID:36945113. |
||||
Links |
IMSR (for Mir142hg) |